Published

Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychopharmacology
Date: 2022-06-01
Source: PubMed
DOI: 10.1007/s00213-021-06049-6
PubMed: 35022823

Authors

Bender D Hellerstein DJ

Watch author

Derived topics and classifications

psilocybin Depression Brain Imaging Aging Clinical Trial Review Article Case Report Observational Study Healthy Volunteers Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogensPsychiatry and Clinical Neurosciences Reports · 2024-05-16 Cardiovascular safety of psychedelic medicine: current status and future directions.Pharmacological reports: PR · 2023-12-01 Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.Current psychiatry reports · 2022-10-01 Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07 The possible place for psychedelics in pharmacotherapy of mental disorders.Pharmacological reports: PR · 2023-12-01 The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent StudiesCurrent Addiction Reports · 2026-08-18 Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.Clinical case reports · 2024-09-01 Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Scientific reports · 2024-02-05